Compare JAZZ & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | HAS |
|---|---|---|
| Founded | 2003 | 1923 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 13.3B |
| IPO Year | 2007 | 1994 |
| Metric | JAZZ | HAS |
|---|---|---|
| Price | $239.79 | $87.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $217.57 | $109.73 |
| AVG Volume (30 Days) | 877.4K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.17 | 2.51 |
| Revenue | $1,618,693,000.00 | ★ $5,365,900,000.00 |
| Revenue This Year | $6.22 | $5.38 |
| Revenue Next Year | $7.68 | $6.48 |
| P/E Ratio | ★ $34.01 | $35.36 |
| Revenue Growth | N/A | ★ 13.06 |
| 52 Week Low | $125.79 | $69.50 |
| 52 Week High | $266.38 | $106.98 |
| Indicator | JAZZ | HAS |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 36.11 |
| Support Level | $236.70 | $83.50 |
| Resistance Level | $242.66 | $89.20 |
| Average True Range (ATR) | 5.77 | 1.97 |
| MACD | -0.36 | -0.66 |
| Stochastic Oscillator | 32.04 | 9.32 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to around 20 million digital tabletop players.